Nephrotoxic drugs: Difference between revisions
No edit summary |
No edit summary |
||
Line 29: | Line 29: | ||
* [[Arsenic]] Poisoning | * [[Arsenic]] Poisoning | ||
* [[Bismuth]] | * [[Bismuth]] | ||
* [[Lead]] Poisoning | * [[Lead]] Poisoning | ||
* [[Lithium]] related kidney disorders | * [[Lithium]] related kidney disorders | ||
Line 36: | Line 35: | ||
:*:* [[Dialysis]] indications: [[Creatinine]] >2.5 or [[Seizure]]s, ALOC, [[Rhabdomyolysis]] | :*:* [[Dialysis]] indications: [[Creatinine]] >2.5 or [[Seizure]]s, ALOC, [[Rhabdomyolysis]] | ||
:* [[Chronic kidney disease]] with [[fibrosis]] | :* [[Chronic kidney disease]] with [[fibrosis]] | ||
* [[Mercury]] Poisoning | |||
==AntiHyperlipidemics== | ==AntiHyperlipidemics== |
Revision as of 16:30, 9 August 2012
WikiDoc Resources for Nephrotoxic drugs |
Articles |
---|
Most recent articles on Nephrotoxic drugs Most cited articles on Nephrotoxic drugs |
Media |
Powerpoint slides on Nephrotoxic drugs |
Evidence Based Medicine |
Cochrane Collaboration on Nephrotoxic drugs |
Clinical Trials |
Ongoing Trials on Nephrotoxic drugs at Clinical Trials.gov Trial results on Nephrotoxic drugs Clinical Trials on Nephrotoxic drugs at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Nephrotoxic drugs NICE Guidance on Nephrotoxic drugs
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Nephrotoxic drugs Discussion groups on Nephrotoxic drugs Patient Handouts on Nephrotoxic drugs Directions to Hospitals Treating Nephrotoxic drugs Risk calculators and risk factors for Nephrotoxic drugs
|
Healthcare Provider Resources |
Causes & Risk Factors for Nephrotoxic drugs |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Nephrotoxic drugs are pharmacotherapies that can lead to a decline in renal function. The drug may need to be discontinued, or the dosing reduced when this happens.
Antibiotics
- Acyclovir (only nephrotoxic in intravenous form)
- Aminoglycosides (10-15% Incidence of Acute Tubular Necrosis)
- Occurs in 10-20% patients on 7 day course
- Results in non-oligurics; increased Creatinine
- A single dose early in septic course is usually safe
- Amphotericin B (Incidence 80-90%)
- Ciprofloxacin
- Levofloxacin
- Pentamidine
- Rifampin
- Sulfonamides
- Tetracycline
Chemotherapy and Immunosuppressants
Heavy Metals
- Polydipsia and Nephrogenic Diabetes Insipidus
- Acute Renal Failure
- Dialysis indications: Creatinine >2.5 or Seizures, ALOC, Rhabdomyolysis
- Chronic kidney disease with fibrosis
- Mercury Poisoning
AntiHyperlipidemics
- Fenofibrate (Tricor)
- Increases Serum Creatinine without significant decrease in GFR
- Serum Creatinine rise is reversible on stopping Fenofibrate
- Associated with Acute Renal Failure due to Rhabdomyolysis
Chemotherapy
- Causes Fanconi's Syndrome
Miscellaneous Drugs
- Chronic Stimulant Laxative use
- Resulting chronic volume depletion and Hypokalemia causes nephropathy
- Radiographic contrast
- ACE Inhibitors
- Expect an increase of Serum Creatinine in Chronic kidney disease
- Low dose Aspirin reduces Renal function in elderly
- Decreased Creatinine Clearance after 2 weeks of use
- Changes persisted for at least 3 weeks off Aspirin
- Low dose Aspirin reduces Renal function in elderly
- Mesalamine (Asacol, Pentasa)
- Mesalamine is an NSAID analog and has systemic absorption from the bowel
- Vasculitis reaction
- Nephrotic Syndrome type reaction